Cargando…

Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association

Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levine, Glenn N., Lange, Richard A., Bairey‐Merz, C. Noel, Davidson, Richard J., Jamerson, Kenneth, Mehta, Puja K., Michos, Erin D., Norris, Keith, Ray, Indranill Basu, Saban, Karen L., Shah, Tina, Stein, Richard, Smith, Sidney C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	AHA Scientific Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721815/ https://www.ncbi.nlm.nih.gov/pubmed/28963100 http://dx.doi.org/10.1161/JAHA.117.002218

Ejemplares similares

Clinical Implications for Exercise at Altitude Among Individuals With Cardiovascular Disease: A Scientific Statement From the American Heart Association
por: Cornwell, William K., et al.
Publicado: (2021)

Caregiver Influences on Eating Behaviors in Young Children: A Scientific Statement From the American Heart Association
por: Wood, Alexis C., et al.
Publicado: (2020)

Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association
por: Lopez, Keila N., et al.
Publicado: (2022)

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association
por: Baker‐Smith, Carissa M., et al.
Publicado: (2021)

Self‐Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association
por: Riegel, Barbara, et al.
Publicado: (2017)

Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management: A Scientific Statement From the American Heart Association
por: Rudd, Nancy A., et al.
Publicado: (2020)

Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association
por: Dahdah, Nagib, et al.
Publicado: (2021)

Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association
por: John, Anitha S., et al.
Publicado: (2022)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

ESR statement on good scientific practice and publishing
Publicado: (2012)

Scientific Statements
Publicado: (2013)

Scientific statement on the maximum residue levels for potassium phosphonates
Publicado: (2022)

Scientific statement on the coverage of bats by the current pesticide risk assessment for birds and mammals
por: Hernández‐Jerez, Antonio, et al.
Publicado: (2019)

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(®) trial
por: Fitchett, David, et al.
Publicado: (2016)

Statement on additional scientific evidence in relation to the essential composition of total diet replacement for weight control
por: Castenmiller, Jacqueline, et al.
Publicado: (2021)

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
por: Swanson, Kelly S., et al.
Publicado: (2020)

Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes
por: Hill, James O., et al.
Publicado: (2013)

Statement of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on the design and conduct of groundwater monitoring studies supporting groundwater exposure assessments of pesticides
por: Hernandez‐Jerez, Antonio, et al.
Publicado: (2023)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

Statement on the active substance flupyradifurone
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the active substance acetamiprid
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
por: Insel, Richard A., et al.
Publicado: (2015)

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods
por: Marco, Maria L., et al.
Publicado: (2021)

ESR Statement on the Validation of Imaging Biomarkers
Publicado: (2020)

ESR statement on portable ultrasound devices
Publicado: (2019)

Statement on non‐dietary exposure on diquat
Publicado: (2018)

Statement on risk mitigation measures on cypermethrin
Publicado: (2019)

The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
por: Salminen, Seppo, et al.
Publicado: (2021)

ESR statement on the stepwise development of imaging biomarkers
Publicado: (2013)

Position Statement on Indications of Echocardiography in Adults - 2019
por: Barberato, Silvio Henrique, et al.
Publicado: (2019)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

ESR statement on new approaches to undergraduate teaching in Radiology
Publicado: (2019)

Statement concerning the review of the approval of the active substance ipconazole
Publicado: (2022)

Statement concerning the review of the approval of the active substance pirimicarb
Publicado: (2023)

Statement on the BfR opinion regarding the toxicity of 2‐chloroethanol
por: Borroto, Jorge, et al.
Publicado: (2022)

European Commission guidelines on clinical audit. Statement by the European Society of Radiology
Publicado: (2011)

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
por: Turck, Dominique, et al.
Publicado: (2022)

Statement on how to interpret the QPS qualification on ‘acquired antimicrobial resistance genes’
por: Koutsoumanis, Konstantinos, et al.
Publicado: (2023)

Radiology in the era of value-based healthcare: a multi-society expert statement from the ACR, CAR, ESR, IS3R, RANZCR, and RSNA
por: Brady, Adrian P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i9tsdn28ka3dmahvgj32vfckk6